Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01822132 · ClinicalTrials.gov registry record · NA
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT01822132 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 76 participants.
The verdict
NCT01822132, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of this protocol is to learn more about impulsive decision making in people who use methamphetamines. The investigators would like to know if a medication called naltrexone changes how people make decisions. The investigators would also like to know whether changes in decision making can be observed by MRI (magnetic resonance imaging). The research is conducted in Portland, OR.
Interventions
- DRUG Placebo
- DRUG Extended release naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01822132
The ClinicalTrials.gov registry entry for NCT01822132 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01822132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01822132 about?
NCT01822132 is a clinical study titled "Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade". The purpose of this protocol is to learn more about impulsive decision making in people who use methamphetamines. The investigators would like to know if a medication called naltrexone changes how people make decisions. The investigators would also like to know whether changes in decision making can...
What is the current status of trial NCT01822132?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2013-05. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01822132?
The interventions under investigation include: Placebo (DRUG), Extended release naltrexone (DRUG).
Who is sponsoring clinical trial NCT01822132?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.